Levetiracetam (Keppra) ๐
Related Subjects:
|Status Epilepticus (Epilepsy)
|Coma management
|Lorazepam
|Phenytoin
|Levetiracetam
|Epilepsy - General Management
|First Seizure
|Epilepsy in Pregnancy
|Febrile seizures
๐ About
- Check BNF entry here for up-to-date dosing and monitoring guidance.
- Broad-spectrum anticonvulsant with a favourable interaction profile.
- Mechanism not fully understood โ binds to synaptic vesicle protein SV2A, modulating neurotransmitter release.
๐งพ Indications
- Monotherapy for partial seizures.
- Adjunctive therapy for partial, myoclonic, and generalised tonicโclonic seizures.
- Status epilepticus (IV, unlicensed but widely used in UK practice).
๐ Dose (Adults)
- Epilepsy (PO):
โ Start: 250 mg once daily for 1โ2 weeks.
โ Increase to 250 mg twice daily.
โ Titrate every 2โ4 weeks up to usual maintenance: 1.5 g BD.
โ Max dose often 3 g/day (BNF).
โ Adjust for renal impairment.
- Status Epilepticus (IV, loading):
โ Consider 40โ60 mg/kg IV infusion over 15 minutes (max 4500 mg).
โ Commonly 50 mg/kg used in UK hospitals.
- Consider Oral Starting 500 mg PO twice daily (BD)
- Status Epilepticus (maintenance, renal adjusted):
โ eGFR 50โ80 mL/min: 1000 mg BD.
โ eGFR 30โ50 mL/min: 750 mg BD.
โ eGFR <30 mL/min: 500 mg BD.
โ Dialysis patients: 500 mg OD (with supplemental dose post-dialysis).
๐ Interactions
- Minimal โ no major CYP450 involvement.
- Safe choice when polypharmacy is a concern (elderly, oncology, transplant patients).
๐ฅ Side Effects
- Neurological: dizziness, somnolence, ataxia, tremor, headache.
- Psychiatric: irritability, agitation, insomnia, mood changes (depression, rarely psychosis).
- Dermatological: rash, StevensโJohnson syndrome (rare), DRESS syndrome.
- Haematological: leucopenia, anaemia (uncommon).
- Generally well tolerated compared with older AEDs.
๐งช Monitoring
- No routine blood monitoring required.
- Check renal function (dose adjustment needed).
- Monitor mood and behavioural side effects, especially in adolescents and young adults.
๐ References